Group One Trading
LFCR icon

Group One Trading’s Lifecore Biomedical LFCR Stock Holding History

Group One Trading’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,300
Closed -$29K – 8322
2025
Q1 		$30.3K Buy
+4,300
New +$26.7K ﹤0.01% 5535
2023
Q4 		– Sell
-14,996
Closed -$104K – 7819
2023
Q3 		$113K Buy
+14,996
New +$137K ﹤0.01% 4339
2018
Q1 		– Sell
-200
Closed -$2.63K – 5080
2017
Q4 		$3K Buy
200
+100
+100% +$1.26K ﹤0.01% 4646
2017
Q3 		$1K Buy
+100
New +$1.32K ﹤0.01% 4706
2016
Q3 		– Sell
-600
Closed -$6K – 4727
2016
Q2 		$6K Hold
600
– – ﹤0.01% 4229
2016
Q1 		$6K Buy
600
+100
+20% +$1.1K ﹤0.01% 4154
2015
Q4 		$6K Buy
+500
New +$6.14K ﹤0.01% 4330
2015
Q1 		– Sell
-1,500
Closed -$21K – 4978
2014
Q4 		$21K Buy
+1,500
New +$19.4K ﹤0.01% 3918
2014
Q2 		– Sell
-892
Closed -$10K – 5339
2014
Q1 		$10K Buy
+892
New +$9.79K ﹤0.01% 4577
2013
Q4 		– Sell
-1,408
Closed -$16.8K – 5382
2013
Q3 		$17K Sell
1,408
-5,475
-80% -$76.4K ﹤0.01% 4258
2013
Q2 		$91K Buy
+6,883
New +$95.2K ﹤0.01% 2909

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's LFCR Position: Q2 2025 in Review

Group One Trading sold out of Lifecore Biomedical (LFCR) in Q2 2025, closing a stake of 4,300 shares — an estimated $29K sold.

Group One Trading first reported a position in LFCR in Q2 2013 and held it in 11 quarters. The position peaked at $113K in Q3 2023. 86 funds tracked by Wall St. Rank hold LFCR as of Q2 2025.

  • Group One Trading reported no remaining Lifecore Biomedical position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 4,300 Lifecore Biomedical shares in Q2 2025, an estimated $29K.
  • Group One Trading first reported a position in Lifecore Biomedical in Q2 2013 and held it in 11 quarters.
  • Group One Trading's Lifecore Biomedical position peaked at $113K in Q3 2023.
  • 86 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.